MedPath

Research to the possible assciation between Chlamydia infection and the development of biliary atresia.

Recruiting
Conditions
Extrahepatic Biliary Atresia, Chlamydia infection
Registration Number
NL-OMON28565
Lead Sponsor
Paul Fockens, MD, PhD Department of Gastroenterology and HepatologyAcademic Medical CenterThe Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

• Biopsy proven biliary atresia

• Underwent Kasai operation

Exclusion Criteria

• Patients with embryonic biliary atresia

• Older then 12 years

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The presence of Chlamydia IgA antibody in serum of Dutch patients with biliary atresia, compared to the control group. The presence of Chlamydia in liver tissue (liver biopsy and fibrotic remnant obtained during Kasai operation) of BA patients as compared to controls, examined by PCR as well as Chlamydia-specific staining by immunohistochemistry.
Secondary Outcome Measures
NameTimeMethod
The presence of Chlamydia IgA antibody in serum of mothers of patients with biliary atresia, compared to the presence of Chlamydia IgA antibody in serum of mothers of the control group and the presence of Chlamydia IgA antibody in the general population.
© Copyright 2025. All Rights Reserved by MedPath